Minerva Neurosciences (NERV) Misses Q4 EPS by 2540c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($25.51), $25.40 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• General Mills (GIS) Tops Q1 EPS by 3c
• Baird Reiterates Outperform Rating on Circle Internet Group (CRCL)
• TETRA Technologies Inc. (TTI) PT Lowered to $12 at Stifel Amid Lack of Desalination Contracts